Asset Allocation

As of December 31, 2025.
Type % Net
Cash 0.35%
Stock 54.18%
Bond 36.32%
Convertible 0.00%
Preferred 0.00%
Other 9.15%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 80.57%
Mid 16.92%
Small 2.51%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 91.86%    % Emerging Markets: 0.09%    % Unidentified Markets: 8.05%

Americas 90.42%
89.03%
Canada 80.96%
United States 8.07%
1.39%
Chile 0.00%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.18%
United Kingdom 0.50%
0.68%
Belgium 0.00%
France 0.29%
Germany 0.01%
Ireland 0.05%
Italy 0.31%
Netherlands 0.00%
Norway 0.00%
Spain 0.00%
0.00%
0.00%
Greater Asia 0.34%
Japan 0.34%
0.00%
0.00%
0.00%
Unidentified Region 8.05%

Bond Credit Quality Exposure

AAA 35.10%
AA 15.79%
A 19.20%
BBB 23.29%
BB 0.21%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.11%
Not Available 6.30%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
29.75%
Materials
5.48%
Consumer Discretionary
3.08%
Financials
19.83%
Real Estate
1.36%
Sensitive
19.59%
Communication Services
1.23%
Energy
4.23%
Industrials
8.46%
Information Technology
5.67%
Defensive
5.45%
Consumer Staples
3.20%
Health Care
0.51%
Utilities
1.74%
Not Classified
45.21%
Non Classified Equity
0.34%
Not Classified - Non Equity
44.87%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 23.06%
Corporate 42.56%
Securitized 2.20%
Municipal 21.72%
Other 10.46%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.48%
Less than 1 Year
0.48%
Intermediate
59.28%
1 to 3 Years
6.93%
3 to 5 Years
15.59%
5 to 10 Years
36.76%
Long Term
38.30%
10 to 20 Years
14.83%
20 to 30 Years
18.33%
Over 30 Years
5.14%
Other
1.94%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial